Introduction {#sec1}
============

1,4-Conjugate addition (the Michael addition) of a nucleophile to the α,β-unsaturated systems (Michael acceptors) is one of the most versatile and fundamental carbon--carbon bond forming reactions in organic synthesis.^[@ref1]^ As depicted in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, the usual Michael addition of a nucleophile to the α,β-unsaturated systems yields the adduct with β-substitution. However, if the substrate has a strong electron-withdrawing group at the β-position, then the Michael addition can be circumvented, which may lead to the regiospecific addition at the α-carbon ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Thus, the addition of a nucleophile to the α-carbon of an α,β-unsaturated system is commonly known as anti-Michael addition, contra-Michael addition, or abnormal Michael reaction.^[@ref2]^ In fact, the addition of nucleophiles to α,β-unsaturated systems in which strong electron-withdrawing substituents redirect the polarity of the double bonds at β-carbon is also a Michael addition concerning the strong electron-withdrawing group and double bond portion as the Michael acceptor. This concept has been explored under suitable conditions on systems with double bonds activated on both sides, and as a result, few synthetic studies and computational reports are available on anti-Michael addition.^[@ref2]−[@ref5]^

![Schematic representation of Michael and anti-Michael addition.](ao-2018-00147c_0002){#fig1}

In recent years, Meyer--Schuster (MS) rearrangement, that is, the conversion of propargyl alcohols to activated olefins (Michael acceptors), has become an attractive reaction because of its simple operation and atom economy.^[@ref6]−[@ref9]^ Although the diverse range of α,β-unsaturated systems are retrieved through MS rearrangement, isatin-derived Michael acceptors have not yet been synthesized from the corresponding propargyl alcohols through MS rearrangement. It is interesting to note that these compounds are known to react in a conjugate addition.^[@ref10]^ Hence, we were interested to develop the first synthesis of such doubly activated olefins through the MS rearrangement and a conjugate addition of these products through the one-pot approach. In continuation of our research interests toward the use of propargyl alcohols as suitable synthons for the synthesis of privileged molecules,^[@ref11]^ herein, we report our investigations on the cascade synthesis of 3-pyrrolyl-indolin-2-ones and 3-azarenyl-indolin-2-ones through a one-pot MS rearrangement, anti-Michael addition, and intramolecular azacyclization sequence.

Results and Discussion {#sec2}
======================

We chose 3-hydroxy-3-(phenylethynyl)indolin-2-one (**1a**) as the model substrate for the MS rearrangement reaction. Initially, **1a** was refluxed in 1,2-dichloroethane (DCE) in the presence of 10 mol % of Ca(OTf)~2~ and Bu~4~NPF~6~ (additive) for 12 h, but no reaction was observed (entry 1, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Indeed, the same is the case with other solvents, such as toluene and water, under reflux conditions (entries 2 and 3). Interestingly, when we switch the solvent to ethanol and reflux the propargyl alcohol **1a** with 10 mol % of Ca(OTf)~2~ and Bu~4~NPF~6~ (additive) for 12 h, MS rearrangement took place and furnished the enone **2a** in 60% yield (entry 4). Encouraged by this result, we examined other alcoholic solvents, such as methanol, isopropanol, and isobutanol. The first two alcohols gave slightly better yields (entries 5 and 6); fortunately, the last one (isobutanol) gave 93% yield in 4 h (entry 7). After identifying the suitable solvent, we aimed to check the role of the Ca(II) catalyst in the rearrangement and hence **1a** was refluxed in isobutanol without catalyst for 6 h (entry 8) and noted that the reaction could not initiate, which confirmed the need for a catalyst. Next, we performed a couple of experiments to see the importance of Ca(II) and additive combination. In the absence of additive Bu~4~NPF~6~, the reaction gave 35% yield of **2a** (entry 9), and in the absence of Ca(OTf)~2~, the reaction could not even initiate (entry 10). Further experiments to minimize the catalyst loadings were unsuccessful, as shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} (entries 11 and 12). The reaction with other catalysts such as Mg(OTf)~2~ gave the poor yield of **2a** (entry 13), *p*-toluenesulfonic acid (TSA) gave a moderate yield of 70% (entry 15), and Cu(OTf)~2~ was found to be ineffective (entry 14). Finally, entry 7 was found to be the optimum condition for the MS rearrangement of **1a** to **2a**.

###### Optimization of MS Rearrangement of Oxindole-Derived Propargyl Alcohol **1a** to **2a**

![](ao-2018-00147c_0009){#fx1}

  entry   catalyst (mol %)                  reaction conditions       yield (%)
  ------- --------------------------------- ------------------------- -----------
  1       Ca(OTf)~2~/Bu~4~NPF~6~, (10/10)   1,2-DCE, 90 °C, 12 h      nr
  2       Ca(OTf)~2~/Bu~4~NPF~6~, (10/10)   toluene, 110 °C, 12 h     nr
  3       Ca(OTf)~2~/Bu~4~NPF~6~, (10/10)   water, 100 °C, 12 h       nr
  4       Ca(OTf)~2~/Bu~4~NPF~6~, (10/10)   EtOH, 90 °C, 12 h         60
  5       Ca(OTf)~2~/Bu~4~NPF~6~, (10/10)   MeOH, 65 °C, 12 h         63
  6       Ca(OTf)~2~/Bu~4~NPF~6~, (10/10)   isopropanol, 90 °C, 6 h   78
  7       Ca(OTf)~2~/Bu~4~NPF~6~, (10/10)   isobutanol, 90 °C, 4 h    93
  8                                         isobutanol, 90 °C, 6 h    nr
  9       Ca(OTf)~2~, (10)                  isobutanol, 90 °C, 8 h    35
  10      Bu~4~NPF~6~, (10)                 isobutanol, 90 °C, 8 h    nr
  11      Ca(OTf)~2~/Bu~4~NPF~6~, (10/5)    isobutanol, 90 °C, 4 h    80
  12      Ca(OTf)~2~/Bu~4~NPF~6~, (5/10)    isobutanol, 90 °C, 4 h    60
  13      Mg(OTf)~2~/Bu~4~NPF~6~, (10/10)   isobutanol, 90 °C, 8 h    40
  14      Cu(OTf)~2~, (10)                  isobutanol, 90 °C, 8 h    nr
  15      *p*-TSA, (10)                     isobutanol, 90 °C, 8 h    70

After establishing the suitable conditions for the MS rearrangement, we explored the scope of this protocol to a diverse range of oxindole-derived propargyl alcohols, and the results are summarized in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. The MS rearrangement reaction showed an excellent substrate scope concerning the substitution of the benzene ring of oxindole, including 5-methyl, 5-chloro, 5-fluoro, and 7-fluoro substitutions, and gave the enones **2a**--**e** in good yields. Gratifyingly, the reaction also tolerated the N-alkyl substitutions of oxindole moiety, such as N-methyl, N-phenyl, N-benzyl, and N-allyl, and furnished the alkenes **2f**--**i**, activated on both sides in good yields. The next possible diversity of this reaction is the alkyne moiety, and we are glad to see that when the phenyl alkyne was changed to (4-methyl)-phenyl, (4-methoxy)-phenyl group, the reaction showed a similar reactivity and yielded the products **2j**--**m** in good yields. It is worth noting that not only aryl alkynes but also aliphatic alkynes, such as cyclohexyl alkyne and *n*-pentyne, took part in the MS rearrangement and resulted in the respective products **2n** and **2o** in moderate yield.

![Substrate Scope of Oxindole-Derived Propargyl Alcohols in Ca(II)-Catalyzed MS Rearrangement](ao-2018-00147c_0005){#sch1}

Encouraged by the broad substrate scope of Ca(II)-catalyzed MS rearrangement of oxindole-derived propargyl alcohols ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}), we were then interested in trapping these activated olefins into a one-pot, tandem reaction. It is to highlight that, so far there is no report available on the MS rearrangement of oxindole-derived propargyl alcohols followed by the one-pot, sequential synthetic reaction. As depicted in [Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, these activated enones are perfect ambident substrates and can undergo two possible modes of conjugate additions, namely, Michael addition and conjugate addition. Interestingly, the observed products are entirely regiospecific. However, the reason for this behavior is not thoroughly investigated. Therefore, we planned for the systematic investigations and theoretical calculations to explain the regiospecificity and hence designed the one-pot, sequential reactions starting from propargyl alcohols.

![Schematic representation of Meyer--Schuster (MS) rearrangement (current and previous).](ao-2018-00147c_0012){#fig2}

The natural bond orbital (NBO) charge distribution of selected compounds (**2a**, **2c**, **2e**, **2f**, **2n**, and **2o**) was studied by performing ab initio (B3LYP/6-31g\*\*) calculations. The results indicate that the nucleophilic addition is more preferred at α-carbon over β-carbon ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). To check this experimentally, we chose 2-methyl quinoline as the nucleophile because oxindole and quinolines are privileged molecules, so the combination (hybrid) of these two privileged molecules would be of more medicinal importance.^[@ref12]^ On the basis of this assumption, **1a** was subjected to MS rearrangement and then quinoline **3a** was added to the reaction and continued for 12 h; gratifyingly, 61% yield of **4a** was obtained in a one-pot, sequential MS rearrangement, conjugate addition,^[@ref13]^ and C~(sp^3^)~--H functionalization sequence ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![NBO charge distribution on the activated C--C double bond.](ao-2018-00147c_0003){#fig3}

![MS Rearrangement, Conjugate Addition, and C~( (sp^3^)~--H Functionalization Cascade](ao-2018-00147c_0010){#sch2}

With the success of the one-pot synthesis of 3-(1-oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one (**4a**) from propargyl alcohol **1a**, we were interested to see the generality of this sequential reactions, and as a result, we synthesized **4b** in 72% yield with **1a** and 7-chloro quinaldine ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Similarly, other oxindole-derived propargyl alcohols also showed excellent reactivity toward quinaldine and 7-chloro-quinaldine and furnished the respective compounds **4c**--**f** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}) in moderate to good yields.

![One-Pot, Sequential MS Rearrangement, Conjugate Addition, and C~(sp^3^)~--H functionalization\
Reaction conditions: all reactions are carried out with 1 equiv of **1**; refluxed in minimum solvent; after MSR, 1.2 equiv of **3** was added; and the temperature was raised to 110 °C.](ao-2018-00147c_0013){#sch3}

With a precedent established by the success of one-pot, sequential reactions between **1** and **3**, we planned to explore the possibility of intramolecular annulation strategy to this sequential one-pot procedure. In this regard, oxindoles bearing densely substituted pyrroles at 3-position were attracted the attention owing to their privileged nature.^[@ref14],[@cit10b]^ So, we aimed the synthesis of these molecules from propargyl alcohols: compound **1a** was subjected to standard conditions of MS rearrangement, and then, aniline and ethyl acetoacetate were added to the reaction mixture and the reaction was continued for 9 h to obtain the desired product **7a** in 75% overall yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Execution of One-Pot, Sequential MS Rearrangement, Anti-Michael Addition, and Azacyclization](ao-2018-00147c_0006){#sch4}

The substrate scope of this one-pot, three-component synthesis of oxindol-3-yl-pyrroles is further investigated; the reaction finds quite generous with respect to propargyl alcohols (**1**), β-keto esters (**5**), and various amines (**6**); and the results are tabulated in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. For example, propargyl alcohol **1a** and ethyl acetoacetate (**5a**) react with aniline (**6a**) and benzyl amines (**6b**) to yield **7a** and **7b** in good yields. Methyl acetoacetate also showed excellent reactivity with **1a** and **6a**, **6b** to furnish **7c** and **7d** in respective yields of 73 and 81%. Not only aryl amines but also aliphatic amines reacted in this one-pot synthesis and furnished the respective products in good yields. In case of cyclic β-keto esters, the reaction worked but gave poor yields of **7w** and **7x**, probably because the rigidity of the cyclic structure slows down the azacyclization step. In case of the compound ethyl 4-(2-oxoindolin-3-yl)-1,5-diphenyl-1*H*-pyrrole-3-carboxylate, the β-enaminoester was prepared separately from ethyl propiolate and aniline and then added to the in situ generated activated alkene and obtained in 58% yield.

###### Substrate Scope of Ca(II)-Catalyzed One-Pot Synthesis of Oxindolyl-Pyrroles[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-00147c_0008){#fx2}

Reaction condition: all reactions were carried out with 1 equiv of **1**, in minimum amount of 2-butanol; after the MSR, 1 equiv of **5** and 1.1 equiv of **6** were added at 90 °C. A enaminoester was pregenerated and added.

Later, we performed the control experiments ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}) to understand the mechanism in detail; the reaction (one-pot, sequential MS rearrangement, conjugate addition, and azacyclization) of **1a** under standard conditions ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}, eq i) works through a stepwise addition, i.e., after noticing the MS rearrangement by thin-layer chromatography, aniline and ethylene--acrylic acid (EAA) should be added. However, it was observed that the mixing of the three reactants together in the presence of Ca(II) could not lead to the product, but only gave the enaminoester (eq ii) and even this enaminoester could add to **1a** (eq iii). Mixing of **2a** with aniline and EAA in the presence of Ca(II) gave the product **7a** (eq v), as well as proved that the conjugate addition is proceeding through the β-enaminoester (eq vi), but not through alkylation of **2a** with EAA, followed by condensation with aniline (eq viii). It also indicated that the catalyst is not required for the conjugate addition and annulation (eqs v and vi).^[@ref14],[@ref15]^ However, the presence of a catalyst is compulsory for the MS rearrangement of propargyl alcohol ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 8). On the basis of these observations, the mechanism for the one-pot synthesis of oxindolyl-pyrrole is presented in [Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}.

![Control Experiments](ao-2018-00147c_0001){#sch5}

![Possible Mechanism](ao-2018-00147c_0007){#sch6}

Further to the NBO charge distribution calculations ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}), we also investigated the experimentally observed formation of product **3** (via α-addition) by comparing the energies of intermediates **α1** and **β1**, which would be formed by α and β-additions, respectively, as shown in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}. The geometries of intermediates were optimized using Hartree--Fock (HF) level theory and 3-21g basis set. The single-point energy (B3LYP/6-31g\*\*) calculations of the optimized structures show that intermediate **α1** is stable by −17.37 kJ/mol compared to intermediate **β1**. Hence, we propose that the formation of enol in intermediate **α1** provides extra stability due to enhanced aromaticity.

![Proposed intermediates of α-addition and β-addition.](ao-2018-00147c_0004){#fig4}

On the basis of these experimental and computational observations, we proposed the mechanism for this one-pot, sequential synthesis of oxindolyl-pyrroles from oxindole-propargyl alcohols ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}).

In conclusion, we developed the first synthetic approach for the Meyer--Schuster rearrangement of isatin-derived propargyl alcohols to the corresponding α,β-unsaturated enones under calcium catalysis. Further, we utilized these activated olefins into one-pot, sequential reactions and synthesized the privileged molecules of medicinal importance, 3-pyrrolyl-indolin-2-ones, and 3-azaarenyl-indolin-2-ones with a broad substrate scope and good yields. This one-pot reaction involves the following sequence of reactions: Meyer--Schuster rearrangement, anti-Michael addition/C~(sp^3^)~--H functionalization, intramolecular azacyclization, and aromatization. Control experiments and computational calculations were performed to describe the feasibility and path of the reaction mechanism.

Experimental Section {#sec3}
====================

General Information {#sec3.1}
-------------------

Unless otherwise noted, the chemicals and solvents purchased were of high-purity commercial grade and used without further purification. Thin-layer chromatography was performed on Merck precoated silica gel plates (60 F~254~) using UV light as a visualizing agent. Silica gel (60--120 mesh) was used for column chromatography. ^1^H NMR and ^13^C NMR spectra were recorded at 500, 400 and 125, 100 MHz, respectively, in CDCl~3~, dimethyl sulfoxide (DMSO)-*d*~6~, and MeOD-*d*~4~ using an internal reference on an Bruker Avance spectrometer. The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, dd = doublet of doublet, t = triplet, q = quartet, and m = multiplet. High-resolution mass spectra (HRMS) were recorded using electrospray ionization time-of-flight (ESI-TOF) mass spectrometry (ESI-MS). Melting points were measured with a MEPA Lab (India) melting point apparatus.

General Experimental Procedure for the Synthesis of Phenacylideneindolin-2-one **2a** {#sec3.2}
-------------------------------------------------------------------------------------

To a 10 mL flask were successively added the respective propargylic alcohol **1a** (100 mg, 0.40 mmol), Ca(OTf)~2~ (13.5 mg, 0.04 mmol), Bu~4~NPF~6~ (15.5 mg, 0.04 mmol), and 3 mL of isobutanol. The resulting mixture was stirred at 90 °C until almost full consumption of **1a** as monitored by thin-layer chromatography, and then, the solvent was evaporated by vacuum and the reaction mixture was directly subjected to flash column chromatography on silica gel using 20--30% petroleum ether/ethyl acetate to afford the corresponding product **2a** (93 mg, 93%).

General Experimental Procedure for the Synthesis of 3-(1-Oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one **4a** {#sec3.3}
-----------------------------------------------------------------------------------------------------------------------

To a 10 mL flask were successively added the respective propargylic alcohol **1a** (100 mg, 0.40 mmol), Ca(OTf)~2~ (13.5 mg, 0.04 mmol), Bu~4~NPF~6~ (15.5 mg, 0.04 mmol), and 3 mL of isobutanol. The resulting mixture was stirred at 90 °C until almost full consumption of **1a** as monitored by thin-layer chromatography, and then, the respective quinaldine **3a** (68.9 mg, 0.48 mmol) was added. The resulting mixture was refluxed at 110 °C until the formation of product, and then, the solvent was evaporated by vacuum and the reaction mixture was directly subjected to flash column chromatography on silica gel (petroleum ether/ethyl acetate) to afford the corresponding product **4a** (96 mg, 61%).

General Experimental Procedure for the Synthesis of Ethyl 2-Methyl-4-(2-oxoindolin-3-yl)-1,5-diphenyl-1*H*-pyrrole-3-carboxylate **7a** {#sec3.4}
---------------------------------------------------------------------------------------------------------------------------------------

To a 10 mL flask were successively added the respective propargylic alcohol **1a** (100 mg, 0.40 mmol), Ca(OTf)~2~ (13.5 mg, 0.04 mmol), Bu~4~NPF~6~ (15.5 mg, 0.04 mmol), and 3 mL of isobutanol. The resulting mixture was stirred at 90 °C until almost full consumption of **1a** as monitored by thin-layer chromatography, and then, the respective 1,3-diketone **5a** (52 mg, 0.40 mmol) and amine **6a** (41 mg, 0.44 mmol) were added. The resulting mixture was stirred at 80 °C until the formation of product, and then, the solvent was evaporated by vacuum and the reaction mixture was directly subjected to flash column chromatography on silica gel (petroleum ether/ethyl acetate) to afford the corresponding product **7a**.

### 3-(2-Oxo-2-phenylethylidene)indolin-2-one (**2a**)^[@cit9e]^ {#sec3.4.1}

Yield: 93 mg (93%) as red solid; mp: 192--193 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.56 (s, 1H), 8.33 (d, *J* = 7.5 Hz, 1H), 8.13 (d, *J* = 7.5 Hz, 2H), 7.89 (s, 1H), 7.56 (t, *J* = 7 Hz, 1H), 7.54 (t, *J* = 8 Hz, 2H), 7.33 (m, 1H), 7.03--7.01 (dd, *J* = 1.5, 8 Hz, 1H), 6.90 (d, *J* = 7.5 Hz, 1H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 191.1, 169.5, 143.3, 137.5, 136.7, 133.8, 132.7, 128.9, 128.8, 128.0, 126.4, 122.8, 120.7, 110.1 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~11~NO~2~ \[M + H\]^+^: 250.0867; found: 250.0864.

### 5-Methyl-3-(2-oxo-2-phenylethylidene)indolin-2-one (**2b**)^[@cit15c]^ {#sec3.4.2}

Yield: 86 mg (86%) as orange solid; mp: 188--189 °C; ^1^H NMR (MeOD-*d*~4~, 500 MHz): δ 8.13 (d, *J* = 6.0 Hz, 1H), 8.01 (d, *J* = 6.5 Hz, 2H), 7.89 (s, 1H), 7.77 (s, 1H), 7.39--7.32 (m, 3H), 6.96--6.89 (m, 2H), 2.44 (s, 3H) ppm; ^13^C NMR (MeOD-*d*~4~, 125 MHz): δ 191.1, 169.6, 145.1, 144.4, 136.5, 134.9, 132.3, 129.3, 128.5, 127.0, 126.1, 122.0, 120.3, 110.0, 20.3 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~17~H~13~NO~2~ \[M + Na\]^+^: 286.0844; found: 286.0841.

### 5-Chloro-3-(2-oxo-2-phenylethylidene)indolin-2-one (**2c**)^[@cit15c]^ {#sec3.4.3}

Yield: 89 mg (89%) as red solid; mp: 202--203 °C; ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 10.97 (s, 1H), 8.12--8.08 (m, 3H), 7.81 (s, 1H), 7.72 (t, *J* = 7.5 Hz, 1H), 7.61 (t, *J* = 8.0 Hz, 2H), 7.43--7.41 (dd, *J* = 2, 8 Hz, 1H), 6.91 (d, *J* = 8.5 Hz, 1H) ppm; ^13^C NMR (DMSO-*d*~6~, 125 MHz): δ 191.4, 168.3, 144.3, 137.4, 136.2, 137.7, 132.9, 129.6, 129.1, 127.6, 126.7, 126.0, 121.8, 112.3 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~10~ClNO~2~ \[M + Na\]^+^: 306.0298; found: 306.0296.

### 5-Fluoro-3-(2-oxo-2-phenylethylidene)indolin-2-one (**2d**)^[@cit15e]^ {#sec3.4.4}

Yield: 71 mg (71%) as orange solid; mp: 187--188 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.48 (s, 1H), 8.12 (t, *J* = 6.4 Hz, 3H), 7.95 (s, 1H), 7.67 (t, *J* = 7.2 Hz, 1H), 7.56 (t, *J* = 7.6 Hz, 2H), 7.15--7.11 (m, 1H), 7.01--6.98 (m, 1H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 190.8, 168.4, 148.4 (d, *J* = 247 Hz, 1C-F), 145.9, 137.3, 135.9, 134.0, 129.0, 128.8, 128.0, 123.6, 123.2, 123.0, 119.4, 119.2, 111.5 ppm; IR (KBr): 1716, 1654, 1597, 1458, 1236, 1168 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~10~FNO~2~ \[M + H\]^+^: 268.0774; found: 268.0778.

### 7-Fluoro-3-(2-oxo-2-phenylethylidene)indolin-2-one (**2e**)^[@cit15a]^ {#sec3.4.5}

Yield: 73 mg (73%) as orange solid; mp: 182--183 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.29 (s, 1H), 8.12 (t, *J* = 7.0 Hz, 2H), 7.94 (s, 1H), 7.67 (t, *J* = 7.5 Hz, 1H), 7.56 (t, *J* = 7.5 Hz, 2H), 7.13 (t, *J* = 8.5 Hz, 2H), 6.99 (d, *J* = 5.5 Hz, 1H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 190.8, 168.4, 147.4 (d, *J* = 255 Hz, 1C-F), 137.3, 134.0, 129.0, 128.8, 128.7, 128.0, 123.6, 123.2, 123.0, 119.4, 119.2 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~16~H~10~FNO~2~ \[M + H\]^+^: 268.0774; found: 268.0778.

### 1-Methyl-3-(2-oxo-2-phenylethylidene)indolin-2-one (**2f**)^[@cit15b]^ {#sec3.4.6}

Yield: 85 mg (85%) as red solid; mp: 101--102 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.31 (d, *J* = 7.5 Hz, 1H), 8.11--8.09 (dd, *J* = 1.0 and 8.0 Hz, 2H), 7.89 (s, 1H), 7.64--7.61 (m, 1H), 7.52 (t, *J* = 8.0 Hz, 2H), 7.39--7.35 (m, 1H), 7.03--7.01 (dd, *J* = 1.5 and 7.5 Hz, 1H), 6.81 (d, *J* = 8.0 Hz, 1H), 3.27 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 191.1, 167.9, 146.0, 137.6, 136.5, 133.7, 132.5, 128.9, 128.8, 127.6, 126.3, 122.8, 120.1, 108.1, 26.3 ppm.

### 3-(2-Oxo-2-phenylethylidene)-1-phenylindolin-2-one (**2g**) {#sec3.4.7}

Yield: 71 mg (71%) as orange solid; mp: 118--119 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.35 (d, *J* = 7.6 Hz, 1H), 8.17--8.15 (dd, *J* = 1.2 and 6.4 Hz, 2H), 8.00 (s, 1H), 7.66 (d, *J* = 7.6 Hz, 1H), 7.60--7.55 (m, 4H), 7.48--7.45 (m, 3H), 7.30 (t, *J* = 7.6 Hz, 1H), 7.10--7.08 (dd, *J* = 1.2 and 7.6 Hz, 1H), 6.82 (d, *J* = 7.6 Hz, 1H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 191.3, 167.3, 145.9, 137.5, 136.3, 134.0, 133.9, 132.5, 129.7, 128.9, 128.8, 128.3, 127.7, 127.1, 126.6, 123.2, 120.1, 109.6 ppm; IR (KBr): 1711, 1655, 1608, 1453, 1329, 1231 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~22~H~15~NO~2~ \[M + Na\]^+^: 348.1001; found: 348.1006.

### 1-Benzyl-3-(2-oxo-2-phenylethylidene)indolin-2-one (**2h**)^[@cit15f]^ {#sec3.4.8}

Yield: 83 mg (83%) as red solid; mp: 123--124 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.34 (d, *J* = 7.5 Hz, 1H), 8.16--8.14 (dd, *J* = 1.5 and 8.0 Hz, 2H), 7.98 (s, 1H), 7.65 (d, *J* = 7 Hz, 1H), 7.56 (t, *J* = 7.0 Hz, 2H), 7.35--7.27 (m, 6H), 7.03--7.01 (dd, *J* = 1.5 and 7.5 Hz, 1H), 6.73 (d, *J* = 8.0 Hz, 1H), 5.00 (s, 2H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 191.2, 168.1, 145.1, 137.5, 136.3, 135.4, 133.8, 132.5, 128.9, 128.8, 127.9, 127.8, 127.7, 127.2, 126.7, 122.8, 120.2, 109.2, 43.9 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~23~H~17~NO~2~ \[M + Na\]^+^: 362.1157; found: 362.1156.

### 1-Allyl-3-(2-oxo-2-phenylethylidene)indolin-2-one (**2i**)^[@cit15f]^ {#sec3.4.9}

Yield: 86 mg (86%) as wine red solid; mp: 93--94 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.32 (d, *J* = 7.6 Hz, 1H), 8.12 (d, *J* = 7.2 Hz, 2H), 7.93 (s, 1H), 7.65 (t, *J* = 7.2 Hz, 1H), 7.63--7.53 (m, 2H), 7.37--7.35 (dd, *J* = 1.2 and 7.6 Hz, 1H), 7.04 (t, *J* = 7.6 Hz, 1H), 6.82 (d, *J* = 7.6 Hz, 1H), 5.91--5.85 (m, 1H), 5.31--5.25 (m, 2H), 4.43--4.41 (m, 2H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 191.2, 167.6, 145.2, 137.5, 136.3, 133.8, 132.5, 131.1, 128.9, 128.8, 127.7, 126.5, 122.8, 120.1, 117.7, 109.1, 42.4 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~19~H~15~NO~2~ \[M + Na\]^+^: 312.1001; found: 312.1001.

### 3-(2-Oxo-2-(*p*-tolyl)ethylidene)indolin-2-one (**2j**)^[@cit15d]^ {#sec3.4.10}

Yield: 91 mg (91%) as orange solid; mp: 203--204 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.28 (d, *J* = 8.0 Hz, 1H), 8.21 (s, 1H), 8.02 (d, *J* = 8.5 Hz, 2H), 7.85 (s, 1H), 7.34--7.31 (m, 3H), 7.01 (t, *J* = 8.0 Hz, 1H), 6.87 (d, *J* = 8.0 Hz, 1H), 2.45 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 190.7, 169.2, 144.9, 143.0, 136.2, 135.1, 132.5, 129.6, 128.9, 127.9, 126.9, 122.8, 120.7, 110.0, 21.8 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~17~H~13~NO~2~ \[M + H\]^+^: 264.1024; found: 264.10212015.

### 3-(2-(4-Methoxyphenyl)-2-oxoethylidene)indolin-2-one (**2k**)^[@cit15d]^ {#sec3.4.11}

Yield: 81 mg (81%) as red solid; mp: 238--239 °C; ^1^H NMR (DMSO-*d*~6~, 400 MHz): δ 10.79 (s, 1H), 8.07--8.05 (dd, *J* = 2.0 and 7.6 Hz, 2H), 7.94 (d, *J* = 7.6 Hz, 1H), 7.69 (s, 1H), 7.35--7.30 (m, 1H), 7.12 (d, *J* = 8.8 Hz, 2H), 6.96--6.87 (m, 2H), 3.87 (s, 3H) ppm; ^13^C NMR (DMSO-*d*~6~, 100 MHz): δ 190.1, 168.6, 164.4, 145.2, 136.0, 133.0, 131.6, 130.3, 127.1, 126.9, 122.1, 120.4, 114.9, 110.7, 56.1 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~17~H~13~NO~3~ \[M + Na\]^+^: 302.0793; found: 302.0789.

### 5-Methyl-3-(2-oxo-2-(*p*-tolyl)ethylidene)indolin-2-one (**2l**) {#sec3.4.12}

Yield: 84 mg (84%) as wine red solid; mp: 166--167 °C; ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 10.69 (s, 1H), 7.97 (d, *J* = 8 Hz, 2H), 7.86 (s, 1H), 7.67 (s, 1H), 7.41 (d, *J* = 8 Hz, 2H), 7.16--7.15 (dd, *J* = 1 and 8 Hz, 1H), 6.77 (d, *J* = 8 Hz, 1H), 2.41 (s, 3H), 2.21 (s, 3H) ppm; ^13^C NMR (DMSO-*d*~6~, 125 MHz): δ 191.1, 168.7, 145.1, 143.0, 136.9, 135.1, 133.7, 130.8, 130.1, 129.1, 127.5, 126.3, 120.5, 110.5, 21.7, 21.1 ppm; IR (KBr): 1717, 1660, 1598, 1463, 1360, 1221 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~18~H~15~NO~2~ \[M + Na\]^+^: 300.1001; found: 300.1001.

### 5-Chloro-1-methyl-3-(2-oxo-2-(*p*-tolyl)ethylidene)indolin-2-one (**2m**)^[@cit9e]^ {#sec3.4.13}

Yield: 79 mg (79%) as orange solid; mp: 183--184 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.37 (s, 1H), 8.01 (d, *J* = 8 Hz, 2H), 7.93 (s, 1H), 7.34 (d, *J* = 8 Hz, 3H), 6.74 (d, *J* = 8.5 Hz, 1H), 3.26 (s, 3H), 2.46 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 190.2, 167.5, 145.1, 144.3, 135.4, 135.0, 132.0, 129.6, 128.9, 128.2, 127.8, 127.7, 121.3, 109.0, 26.3, 21.8 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~18~H~14~ClNO~2~ \[M + Na\]^+^: 334.0611; found: 334.0611.

### 3-(2-Cyclohexyl-2-oxoethylidene)indolin-2-one (**2n**) {#sec3.4.14}

Yield: 61 mg (61%) as red solid; mp: 164--165 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.52 (d, *J* = 7.5 Hz, 1H), 7.83 (s, 1H), 7.35--7.32 (m, 1H), 7.25 (s, 1H), 7.05 (t, *J* = 7.5 Hz, 1H), 6.85 (d, *J* = 8 Hz, 1H), 2.70--2.65 (m, 1H), 2.01--1.99 (m, 2H), 1.87--1.83 (m, 2H), 1.74--1.71 (m, 1H), 1.46--1.35 (m, 5H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 204.1, 169.3, 143.0, 135.7, 132.7, 128.3, 127.5, 122.9, 120.8, 109.8, 52.1, 28.2, 25.7, 25.5 ppm; IR (KBr): 1710, 1654, 1602, 1463, 1329, 1225 cm^--1^; anal. calcd for C~16~H~17~NO~2~: C, 75.27; H, 6.71; N, 5.49; found: C, 75.36; H, 6.68; N, 5.54.

### 3-(2-Oxopentylidene)indolin-2-one (**2o**) {#sec3.4.15}

Yield: 66 mg (66%) as pale brown solid; mp: 171--172 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.56 (d, *J* = 8.0 Hz, 1H), 7.77 (s, 1H), 7.35 (t, *J* = 7.6 Hz, 1H), 7.18 (s, 1H), 7.06 (t, *J* = 8.0 Hz, 1H), 6.85 (d, *J* = 7.6 Hz, 1H), 2.75 (t, *J* = 7.2 Hz, 2H), 1.80--1.74 (m, 2H), 1.01 (t, *J* = 7.2 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 201.2, 169.8, 143.3, 135.4, 132.9, 128.4, 127.7, 122.9, 120.7, 110.0, 46.9, 17.4, 13.6 ppm; IR (KBr): 1711, 1644, 1598, 1453, 1329, 1221 cm^--1^; anal. calcd for C~13~H~13~NO~2~: C, 72.54; H, 6.09; N, 6.51; found: C, 72.60; H, 6.01; N, 6.54.

### 3-(1-Oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one (**4a**)^[@ref11]^ {#sec3.4.16}

Yield: 96 mg (61%) as brown solid; mp: 135--136 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.67 (s, 1H), 8.18 (d, *J* = 8.0 Hz, 2H), 7.98--7.91 (m, 2H), 7.44--7.15 (m, 9H), 6.85 (d, *J* = 8.4 Hz, 1H), 6.78 (d, *J* = 8.0 Hz, 1H), 5.30--5.28 (m, 1H), 3.79 (s, 1H), 3.56--3.50 (m, 1H), 3.39--3.33 (m, 1H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 200.4, 178.1, 158.4, 147.6, 140.2, 136.1, 135.7, 133.3, 132.0, 129.3, 128.8, 128.3, 128.1, 127.6, 127.4, 126.0, 125.6, 125.3, 122.1, 111.7, 110.5, 46.5, 45.8, 36.0 ppm.

### 3-(3-(7-Chloroquinolin-2-yl)-1-oxo-1-phenylpropan-2-yl)indolin-2-one (**4b**) {#sec3.4.17}

Yield: 123 mg (72%) as white solid; mp: 163--164 °C; ^1^H NMR (DMSO-*d*~6~, 500 MHz): δ 10.55 (s, 1H), 8.21 (d, *J* = 8.5 Hz, 1H), 8.09 (d, *J* = 7.5 Hz, 2H), 7.92 (d, *J* = 9.0 Hz, 1H), 7.66--7.51 (m, 5H), 7.38 (d, *J* = 8.5 Hz, 1H), 7.17--7.14 (m, 2H), 6.90--6.82 (m, 2H), 5.14--5.10 (m, 1H), 3.79 (s, 1H), 3.34--3.37 (m, 1H), 3.08--3.03 (m, 1H) ppm; ^13^C NMR (DMSO-*d*~6~, 125 MHz): δ 201.3, 177.6, 160.9, 147.5, 143.5, 136.8, 136.4, 134.2, 133.6, 130.2, 129.3, 128.9, 128.5, 127.2, 127.0, 126.9, 125.4, 125.0, 122.9, 121.6, 109.8, 46.2, 44.9, 35.6 ppm; IR (KBr): 3253, 2965, 1724, 1695, 1473, 1440 cm^--1^; anal. calcd for C~26~H~19~ClN~2~O~2~: C, 73.15; H, 4.49; N, 6.56; found: C, 73.26; H, 4.53; N, 6.48.

### 3-(1-Oxo-3-(quinolin-2-yl)-1-(*p*-tolyl)propan-2-yl)indolin-2-one (**4c**) {#sec3.4.18}

Yield: 104 mg (68%) as pale brown solid; mp: 146--147 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.99 (s, 1H), 8.13 (d, *J* = 8.0 Hz, 2H), 7.92--7.88 (m, 2H), 7.67 (d, *J* = 7.5 Hz, 1H), 7.57 (t, *J* = 7.5 Hz, 1H), 7.41--7.39 (m, 1H), 7.31--7.26 (m, 3H), 7.19--7.13 (m, 2H), 7.07--6.99 (m, 1H), 6.84 (d, *J* = 8.0 Hz, 1H), 5.29--5.26 (m, 1H), 3.80 (s, 1H), 3.49--3.47 (m, 1H), 3.23--3.47 (m, 1H), 2.42 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 200.3, 179.0, 158.9, 147.6, 143.9, 141.9, 135.8, 133.5, 129.4, 129.1, 129.0, 128.9, 128.8, 128.7, 128.1, 127.3, 126.8, 126.7, 125.7, 125.1, 122.2, 122.1, 109.8, 46.3, 46.1, 35.7, 21.6 ppm; IR (KBr): 3214, 2953, 1729, 1698, 1483, 1431 cm^--1^; anal. calcd for C~27~H~22~N~2~O~2~: C, 79.78; H, 5.46; N, 6.89; found: C, 79.65; H, 5.42; N, 6.94.

### 3-(3-(7-Chloroquinolin-2-yl)-1-oxo-1-(*p*-tolyl)propan-2-yl)indolin-2-one (**4d**) {#sec3.4.19}

Yield: 117 mg (71%) as pale white solid; mp: 133--139 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.13 (d, *J* = 8.0 Hz, 3H), 7.92--7.88 (m, 2H), 7.64 (d, *J* = 8.5 Hz, 1H), 7.39--7.15 (m, 6H), 7.01 (t, *J* = 7.5 Hz, 1H), 6.84 (d, *J* = 7.5 Hz, 1H), 5.29--5.25 (m, 1H), 3.81 (s, 1H), 3.51--3.46 (m, 1H), 3.24--3.21 (m, 1H), 2.45 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 200.1, 178.4, 160.1, 148.0, 144.1, 141.5, 135.6, 134.9, 133.3, 129.5, 128.9, 128.7, 128.5, 128.2, 128.0, 126.8, 126.7, 125.1, 122.3, 122.2, 109.5, 46.0, 45.8, 35.6, 21.7 ppm; IR (KBr): 3233, 2987, 1731, 1706, 1477, 1421 cm^--1^; anal. calcd for C~27~H~21~ClN~2~O~2~: C, 73.55; H, 4.80; N, 6.35; found: C, 73.45; H, 4.85; N, 6.29.

### 5-Chloro-3-(1-oxo-1-phenyl-3-(quinolin-2-yl)propan-2-yl)indolin-2-one (**4e**) {#sec3.4.20}

Yield: 84 mg (56%) as white solid; mp: 183--184 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 9.12 (s, 1H), 8.24 (d, *J* = 7.6 Hz, 1H), 7.93 (d, *J* = 7.6 Hz, 2H), 7.87 (d, *J* = 4.4 Hz, 1H), 7.69--7.50 (m, 3H), 7.40--7.28 (m, 3H), 7.20--7.17 (m, 2H), 7.02 (d, *J* = 7.2 Hz, 1H), 6.87 (d, *J* = 8.0 Hz, 1H), 5.33--5.31 (m, 1H), 3.82 (s, 1H), 3.35--3.50 (m, 1H), 3.25--3.20 (m, 1H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 200.4, 178.4, 158.4, 147.6, 140.2, 136.1, 135.7, 133.3, 132.0, 129.3, 128.8, 128.3, 128.1, 127.6, 127.4, 126.0, 125.6, 125.3, 122.1, 111.7, 110.5, 46.5, 45.8, 36.0 ppm; IR (KBr): 3227, 2941, 1729, 1687, 1473, 1438 cm^--1^; anal. calcd for C~26~H~19~ClN~2~O~2~: C, 73.15; H, 4.49; N, 6.56; found: C, 73.26; H, 4.45; N, 6.62.

### 3-(3-(7-Chloroquinolin-2-yl)-1-oxo-1-phenylpropan-2-yl)-1-methylindolin-2-one (**4f**) {#sec3.4.21}

Yield: 109 mg (66%) as brown solid; mp: 117--118 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.24 (d, *J* = 7.2 Hz, 1H), 7.93--7.89 (m, 2H), 7.72 (d, *J* = 8.0 Hz, 1H), 7.63--7.30 (m, 7H), 7.12 (d, *J* = 8.4 Hz, 1H), 7.04 (s, 1H), 6.75 (d, *J* = 7.6 Hz, 1H), 5.36--5.31 (m, 1H), 3.80 (s, 1H), 3.52--3.46 (m, 1H), 3.46--3.27 (m, 1H), 3.06 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 200.8, 176.4, 158.7, 147.6, 144.5, 136.0, 135.7, 133.1, 129.7, 128.9, 128.8 (2C), 128.4, 128.2 (2C), 127.3, 126.7, 126.2, 128.8, 124.8, 122.3, 122.0, 107.9, 46.2, 45.5, 35.9, 26.1 ppm; IR (KBr): 3202, 2932, 1726, 1619, 1469, 1423 cm^--1^; anal. calcd for C~27~H~21~ClN~2~O~2~: C, 73.55; H, 4.80; N, 6.35; found: C, 73.65; H, 4.76; N, 6.28.

### Ethyl 2-Methyl-4-(2-oxoindolin-3-yl)-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7a**)^[@ref14]^ {#sec3.4.22}

Yield: 65 mg (75%) as pale white solid; mp: 231--232 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.89 (s, 1H), 7.32--7.17 (m, 10H), 6.96--6.93 (m, 4H), 4.69 (s, 1H), 4.00--3.86 (m, 2H), 2.39 (s, 3H), 0.99 (t, *J* = 9.0 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 180.6, 164.8, 141.5, 138.3, 137.7, 136.3, 131.5, 130.9, 130.8, 128.9, 128.5, 128.1, 128.0, 127.7, 127.2, 123.1, 121.9, 114.8, 110.5, 109.2, 59.0, 45.7, 14.1, 13.0 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~24~N~2~O~3~ \[M + Na\]^+^: 459.1684; found: 459.1685.

### Ethyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-phenyl-1*H*-pyrrole-3-carboxylate (**7b**)^[@ref14]^ {#sec3.4.23}

Yield: 64 mg (71%) as pale white solid; mp: 210--211 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.26 (s, 1H), 7.36--7.30 (m, 7H), 7.18--7.14 (m, 3H), 6.95 (d, *J* = 8.8 Hz, 4H), 5.00 (s, 2H), 4.53 (s, 1H), 3.93--3.90 (m, 2H), 2.45 (s, 3H), 0.97 (t, *J* = 6.8 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.2, 164.8, 141.3, 137.5, 137.4, 136.3, 131.6, 130.6, 128.8, 128.6, 128.3, 128.1, 127.3, 127.2, 125.6, 123.0, 121.9, 114.7, 110.1, 109.0, 58.9, 48.0, 45.7, 14.1, 12.0 ppm; HRMS (ESI-TOF): *m*/*z* calcd for C~29~H~26~N~2~O~3~ \[M + Na\]^+^: 473.1841; found: 473.1840.

### Methyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-phenyl-1*H*-pyrrole-3-carboxylate (**7c**) {#sec3.4.24}

Yield: 60 mg (69%) as pale white solid; mp: 201--202 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 9.01 (s, 1H), 7.36--7.26 (m, 8H), 7.16 (t, *J* = 5.5 Hz, 1H), 6.95--6.94 (m, 5H), 5.07 (s, 2H), 4.55 (s, 1H), 3.35 (s, 3H), 2.45 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 180.7, 165.2, 141.5, 137.7, 137.4, 136.3, 131.5, 131.3, 130.6, 128.8, 128.7, 128.6, 127.3, 127.2, 125.6, 122.9, 121.9, 114.9, 109.9, 109.1, 49.6, 48.0, 45.8, 11.7 ppm; IR (KBr): 3060, 2924, 1713, 1662, 1466, 1351 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~24~N~2~O~3~ \[M + Na\]^+^: 459.1684; found: 459.1683.

### Methyl 2-Methyl-4-(2-oxoindolin-3-yl)-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7d**) {#sec3.4.25}

Yield: 61 mg (73%) as pale solid; mp: 212--213 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.11 (s, 1H), 7.32--7.17 (m, 10H), 6.97 (t, *J* = 7.2 Hz, 2H), 6.91 (t, *J* = 8.0 Hz, 2H), 4.66 (s, 1H), 3.39 (s, 3H), 2.38 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.0, 165.2, 141.1, 138.3, 137.6, 136.3, 131.4, 130.9, 130.7, 129.0, 128.4, 128.2, 128.0, 127.7, 127.3, 123.2, 122.0, 114.9, 110.2, 108.8, 49.8, 45.5, 12.8 ppm; IR (KBr): 3215, 2974, 1714, 1682, 1423, 1364 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~27~H~22~N~2~O~3~ \[M + Na\]^+^: 445.1528; found: 445.1527.

### Ethyl 1-Benzyl-4-(5-chloro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1*H*-pyrrole-3-carboxylate (**7e**) {#sec3.4.26}

Yield: 69 mg (81%) as white solid; mp: 208--209 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.61 (s, 1H), 7.37--7.13 (m, 6H), 6.95 (d, *J* = 7.5 Hz, 2H), 6.89--6.81 (m, 5H), 5.05 (s, 2H), 4.50 (s, 1H), 3.96--3.93 (m, 2H), 2.46 (s, 3H), 1.02 (t, *J* = 7.5 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 179.1, 163.7, 140.2, 136.5, 136.4, 135.3, 130.5, 129.6, 128.2, 127.8, 127.6, 127.2, 126.3, 126.1, 124.6, 121.9, 120.9, 113.6, 109.1, 107.9, 57.9, 46.9, 44.7, 13.0, 10.9 ppm; IR (KBr): 2924, 1710, 1649, 1600, 1449, 1361 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~29~H~25~ClN~2~O~3~ \[M + Na\]^+^: 507.1451; found: 507.1452.

### Ethyl 4-(5-Chloro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7f**) {#sec3.4.27}

Yield: 62 mg (76%) as white solid; mp: 265--266 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.46 (s, 1H), 7.32--7.17 (m, 9H), 7.00--6.90 (m, 4H), 4.69 (s, 1H), 3.98--3.89 (m, 2H), 2.38 (s, 3H), 1.00 (t, *J* = 7.2 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.6, 164.8, 141.5, 138.3, 137.7, 136.3, 131.5, 130.9, 130.8, 128.9, 128.5, 128.1, 128.0, 127.7, 127.2, 123.1, 121.9, 114.8, 110.5, 109.2, 59.0, 45.7, 14.1, 13.0 ppm; IR (KBr): 3264, 2927, 1701, 1613, 1484, 1381 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~23~ClN~2~O~3~ \[M + Na\]^+^: 493.1270; found: 493.1274.

### Methyl 1-Benzyl-4-(5-chloro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1*H*-pyrrole-3-carboxylate (**7g**) {#sec3.4.28}

Yield: 56 mg (68%) as white solid; mp: 256--257 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.83 (s, 1H), 7.38--7.34 (m, 5H), 7.29 (t, *J* = 7.5 Hz, 3H), 7.13 (s, 1H), 6.95--6.88 (m, 4H), 5.06 (s, 2H), 4.51 (s, 1H), 3.40 (s, 3H), 2.45 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 179.8, 165.0, 140.0, 137.8, 137.2, 136.5, 133.2, 130.3, 128.9, 128.8, 128.7, 128.6, 127.4, 127.2, 127.1, 125.6, 123.4, 114.3, 109.9, 109.7, 49.8, 48.1, 45.8, 11.9 ppm; IR (KBr): 3124, 2936, 1716, 1679, 1543, 1264 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~23~ClN~2~O~3~ \[M + Na\]^+^: 493.1295; found: 493.1299.

### Methyl 4-(5-Chloro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7h**) {#sec3.4.29}

Yield: 56 mg (70%) as white solid; mp: 276--277 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.80 (s, 1H), 7.33--7.22 (m, 9H), 7.14 (d, *J* = 7.5 Hz, 2H), 6.94 (s, 1H), 6.85 (d, *J* = 8.0 Hz, 1H), 4.67 (s, 1H), 3.44 (s, 3H), 2.38 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 180.0, 165.0, 140.0, 138.5, 137.5, 136.4, 133.2, 130.9, 130.5, 129.0, 128.5, 128.3, 128.2, 128.1, 127.9, 127.3, 127.2, 123.5, 114.3, 109.9, 49.9, 45.7, 12.9 ppm; IR (KBr): 3315, 3122, 1704, 1683, 1452, 1298 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~27~H~21~ClN~2~O~3~ \[M + Na\]^+^: 479.1138; found: 479.1138.

### Methyl 4-(5-Fluoro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7i**) {#sec3.4.30}

Yield: 64 mg (79%) as pale white solid; mp: 220--221 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.95 (s, 1H), 7.34--7.22 (m, 9H), 6.85 (s, 2H), 6.74--6.70 (m, 2H), 4.67 (s, 1H), 3.41 (s, 3H), 2.38 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 180.4, 165.1, 158.9 (d, *J* = 239.8 Hz, 1C-F), 138.5, 137.5, 136.4, 130.9, 130.5, 129.2, 129.0, 128.5, 128.2, 128.1, 127.8, 127.5, 127.0, 118.5, 115.1, 114.4, 110.0, 49.8, 46.1, 12.8 ppm; IR (KBr): 3253, 2924, 1714, 1659, 1613, 1479 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~27~H~21~FN~2~O~3~ \[M + Na\]^+^: 463.1434; found: 464.1443.

### Ethyl 4-(7-Fluoro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7j**) {#sec3.4.31}

Yield: 52 mg (62%) as white solid; mp: 225--226 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 7.85 (s, 1H), 7.28--7.21 (m, 9H), 6.99--6.90 (m, 3H), 6.81 (d, *J* = 7.6 Hz, 1H), 4.70 (s, 1H), 4.00--3.94 (q, 2H), 2.38 (s, 3H), 1.05 (t, *J* = 7.2 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 179.1, 164.7, 146.2 (d, *J* = 253 Hz, 1C-F), 145.5, 138.3, 137.6, 136.3, 134.3, 134.2, 130.9, 130.6, 128.7, 128.6, 128.4, 128.1, 127.8, 127.2, 122.5, 122.4, 118.9, 114.4, 114.3, 114.2, 110.5, 59.1, 45.8, 14.1, 13.0 ppm; IR (KBr): 3202, 3046, 1716, 1644, 1496, 1444 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~23~FN~2~O~3~ \[M + Na\]^+^: 477.1590; found: 477.1593.

### Ethyl 4-(7-Fluoro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1-(*p*-tolyl)-1*H*-pyrrole-3-carboxylate (**7k**) {#sec3.4.32}

Yield: 55 mg (63%) as pale white solid; mp: 235--236 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 7.99 (s, 1H), 7.26--7.01 (m, 9H), 6.98--6.89 (m, 2H), 6.79 (d, *J* = 7.5 Hz, 1H), 4.69 (s, 1H), 3.99--3.93 (m, 2H), 2.36 (s, 3H), 2.34 (s, 3H), 1.04 (t, *J* = 7.0 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 178.8, 164.8, 146.4 (d, *J* = 247 Hz, 1C-F), 138.3, 138.0, 138.2, 136.4, 135.0, 132.0, 130.9, 128.8, 128.7, 128.2, 128.1, 127.7, 120.2, 118.9, 114.2, 114.1, 110.3, 59.1, 45.8, 21.0, 14.1, 12.9 ppm; IR (KBr): 3149, 3032, 2924, 1722, 1652, 1450 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~29~H~25~FN~2~O~3~ \[M + Na\]^+^: 491.1747; found: 491.1749.

### Ethyl 1-Benzyl-4-(7-fluoro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1*H*-pyrrole-3-carboxylate (**7l**) {#sec3.4.33}

Yield: 57 mg (66%) as pale white solid; mp: 231--232 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 7.74 (s, 1H), 7.36--7.30 (m, 7H), 6.96--6.92 (m, 5H), 6.75 (d, *J* = 7.6 Hz, 1H), 5.05 (s, 2H), 4.55 (s, 1H), 3.96--3.94 (m, 2H), 2.45 (s, 3H), 1.02 (t, *J* = 6.8 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 178.6, 164.7, 148.3 (d, *J* = 239 Hz, 1C-F), 137.6, 137.3, 136.4, 135.2, 134.3, 130.4, 128.8, 128.7, 128.6, 125.6, 122.4, 122.3, 118.8, 114.3, 114.3, 114.2, 110.0, 59.0, 48.0, 45.8, 14.1, 12.0 ppm; IR (KBr): 3205, 2926, 1719, 1593, 1461, 1209 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~29~H~25~FN~2~O~3~ \[M + H\]^+^: 469.1927; found: 469.1930.

### Methyl 4-(7-Fluoro-2-oxoindolin-3-yl)-2-methyl-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7m**) {#sec3.4.34}

Yield: 54 mg (64%) as pale white solid; mp: 238--239 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.97 (s, 1H), 7.33--7.17 (m, 9H), 6.85 (s, 2H), 6.71 (d, *J* = 8.8 Hz, 2H), 4.67 (s, 1H), 3.42 (s, 3H), 2.38 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.5, 165.1, 158.5 (d, *J* = 263 Hz, 1C-F), 138.5, 137.5, 136.4, 133.2, 133.1, 130.9, 130.5, 129.2, 129.0, 128.4, 128.3, 128.2, 127.9, 118.5, 115.1, 114.4, 110.0, 49.9, 46.1, 12.9 ppm; IR (KBr): 3207, 2970, 1720, 1643, 1504, 1262 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~27~H~21~FN~2~O~3~ \[M + H\]^+^: 441.1614; found: 441.1613.

### Methyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-(*p*-tolyl)-1*H*-pyrrole-3-carboxylate (**7n**) {#sec3.4.35}

Yield: 56 mg (66%) as pale white solid; mp: 226--227 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 9.29 (s, 1H), 7.37--7.29 (m, 8H), 7.18--7.16 (m, 5H), 5.07 (s, 2H), 4.56 (s, 1H), 3.36 (s, 3H), 2.44 (s, 3H), 2.35 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.9, 165.2, 141.5, 138.5, 137.6, 137.5, 136.3, 131.6, 129.4, 128.8, 128.6, 127.6, 127.3, 127.2, 125.6, 122.9, 121.8, 114.8, 109.8, 109.1, 49.6, 47.9, 45.8, 21.2, 11.7 ppm; IR (KBr): 3145, 2967, 1704, 1683, 1402, 1263 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~29~H~26~N~2~O~3~ \[M + H\]^+^: 473.1833; found: 473.1842.

### Ethyl 1-Benzyl-5-(4-methoxyphenyl)-2-methyl-4-(2-oxoindolin-3-yl)-1*H*-pyrrole-3-carboxylate (**7o**) {#sec3.4.36}

Yield: 53 mg (65%) as pale white solid; mp: 189--190 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.49 (s, 1H), 7.36--7.16 (m, 5H), 6.96--6.89 (m, 8H), 5.05 (s, 2H), 4.53 (s, 1H), 3.92--3.89 (m, 2H), 3.79 (s, 3H), 2.45 (s, 3H), 0.95 (t, *J* = 7.0 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 164.8, 159.8, 141.4, 137.5, 137.3, 136.0, 132.6, 131.7, 128.8, 128.6, 127.3, 127.1, 125.6, 122.9, 122.8, 121.8, 114.6, 114.1, 110.0, 109.1, 58.9, 55.2, 47.9, 45.9, 14.0, 11.9 ppm; IR (KBr): 3194, 2874, 1726, 1664, 1489, 1245 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~30~H~28~N~2~O~4~ \[M + Na\]^+^: 503.1947; found: 503.1948.

### Methyl 1-Butyl-4-(5-chloro-2-oxoindolin-3-yl)-2-methyl-5-phenyl-1*H*-pyrrole-3-carboxylate (**7p**) {#sec3.4.37}

Yield: 52 mg (68%) as pale brown solid; mp: 158--159 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.54 (s, 1H), 7.54--7.44 (m, 4H), 7.21 (s, 1H), 7.10 (s, 1H), 6.84--6.79 (m, 2H), 4.39 (s, 1H), 3.77 (t, *J* = 7.5 Hz, 2H), 3.38 (s, 3H), 2.57 (s, 3H), 1.53--1.47 (m, 2H), 1.21--1.18 (m, 2H), 0.79 (t, *J* = 8.0 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 179.8, 165.0, 139.9, 137.1, 135.6, 133.3, 131.9, 131.5, 130.9, 128.7, 127.1, 127.0, 13.4, 114.0, 109.7, 108.9, 49.6, 45.7, 44.2, 32.6, 19.8, 13.4, 11.7 ppm; IR (KBr): 3255, 2919, 1795, 1708, 1563, 1489 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~25~H~25~ClN~2~O~3~ \[M + Na\]^+^: 459.1451; found: 459.1458.

### Ethyl 1-Butyl-2-methyl-4-(2-oxoindolin-3-yl)-5-phenyl-1*H*-pyrrole-3-carboxylate (**7q**)^[@ref14]^ {#sec3.4.38}

Yield: 57 mg (69%) as pale white solid; mp: 175--176 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 9.03 (s, 1H), 7.53--7.41 (m, 5H), 7.10 (d, *J* = 7.0 Hz, 2H), 6.86--6.78 (m, 2H), 4.39 (s, 1H), 3.93--3.89 (m, 2H), 3.78--3.76 (m, 2H), 2.58 (s, 3H), 1.55--1.21 (m, 2H), 1.20--1.16 (m, 2H), 0.98 (t, *J* = 7.0 Hz, 3H), 0.80 (t, *J* = 7.5 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.1, 164.7, 140.2, 136.9, 135.6, 133.4, 131.4, 131.0, 128.6, 127.0, 123.3, 113.9, 110.0, 109.3, 58.8, 45.8, 44.2, 32.7, 19.8, 14.1, 13.4, 11.9 ppm.

### Methyl 1-Benzyl-5-cyclohexyl-2-methyl-4-(2-oxoindolin-3-yl)-1*H*-pyrrole-3-carboxylate (**7r**) {#sec3.4.39}

Yield: 47 mg (54%) as pale white solid; mp: 168--169 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.59 (s, 1H), 7.39--7.28 (m, 3H), 7.19 (d, *J* = 7.5 Hz, 1H), 7.01--6.92 (m, 5H), 5.16 (s, 2H), 4.98 (s, 1H), 3.35 (s, 3H), 2.75--2.63 (m, 1H), 2.45 (s, 3H), 1.91--1.87 (m, 2H), 1.80--1.58 (m, 8H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.2, 165.2, 141.5, 138.0, 137.3, 131.5, 128.9, 128.7, 127.5, 127.2, 125.6, 125.4, 123.0, 121.9, 112.5, 108.9, 65.8, 49.5, 45.5, 36.5, 33.3, 27.3, 25.3, 11.7 ppm; IR (KBr): 3273, 2932, 1705, 1618, 1530, 1445 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~30~N~2~O~3~ \[M + Na\]^+^: 465.2154; found: 465.2153.

### Ethyl 1-Benzyl-2-methyl-4-(2-oxoindolin-3-yl)-5-propyl-1*H*-pyrrole-3-carboxylate (**7s**) {#sec3.4.40}

Yield: 56 mg (57%) as pale brown solid; mp: 179--180 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.19 (s, 1H), 7.39--7.29 (m, 4H), 7.19 (t, *J* = 7.5 Hz, 1H), 6.99--6.91 (m, 4H), 5.15 (s, 2H), 4.65 (s, 1H), 3.92--3.88 (m, 2H), 2.65--2.58 (m, 2H), 2.42 (s, 3H), 1.55--1.50 (m, 2H), 0.98--0.93 (m, 6H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 179.9, 164.8, 141.5, 137.1, 136.7, 133.9, 131.4, 128.9, 128.8, 127.5, 127.2, 125.5, 125.4, 123.0, 121.9, 113.0, 109.5, 109.0, 58.8, 47.0, 45.3, 26.5, 24.7, 14.1, 14.0, 11.7 ppm; IR (KBr): 3253, 2926, 1719, 1495, 1209, 1120 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~26~H~28~N~2~O~3~ \[M + Na\]^+^: 439.1997; found: 439.1992.

### Methyl 1-Benzyl-2-methyl-4-(1-methyl-2-oxoindolin-3-yl)-5-phenyl-1*H*-pyrrole-3-carboxylate (**7t**) {#sec3.4.41}

Yield: 58 mg (65%) as white solid; mp: 162--163 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 7.35--7.21 (m, 8H), 6.75--6.94 (m, 4H), 6.84 (d, *J* = 7.5 Hz, 2H), 5.07 (s, 2H), 4.49 (s, 1H), 3.31 (s, 3H), 3.25 (s, 3H), 2.43 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 178.0, 165.1, 144.2, 137.6, 137.4, 136.2, 130.8, 130.6, 128.8, 128.7, 128.6 (2), 127.3, 127.2, 125.6, 122.6, 122.0, 115.0, 109.8, 107.1, 49.8, 48.0, 45.2, 32.0, 11.7 ppm; IR (KBr): 3016, 2944, 1703, 1610, 1454, 1356 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~29~H~26~N~2~O~3~ \[M + H\]^+^: 451.2022; found: 451.2018.

### Ethyl 1-Benzyl-4-(5-chloro-2-oxoindolin-3-yl)-2,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7u**) {#sec3.4.42}

Yield: 55 mg (58%) as pale brown solid; mp: 248--149 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.01 (s, 1H), 7.36--7.31 (m, 10H), 7.16--7.10 (m, 4H), 6.94 (s, 1H), 6.79 (d, *J* = 8.0 Hz, 1H), 6.48 (s, 2H), 4.95 (s, 2H), 4.52 (s, 1H), 3.76--3.72 (m, 2H), 0.07 (t, *J* = 7.0 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 180.1, 164.0, 141.5, 140.1, 137.9, 131.3, 130.7, 130.6, 130.0, 128.8, 128.6, 128.3 (2), 128.2, 127.6, 127.4, 127.3, 127.0, 126.1, 125.7, 123.0, 121.9, 116.0, 109.2, 59.0, 48.6, 45.5, 13.5 ppm; IR (KBr): 3266, 2982, 1706, 1609, 1488, 1218 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~34~H~27~ClN~2~O~3~ \[M + Na\]^+^: 569.1608; found: 569.1607.

### 3-(4-Acetyl-5-methyl-1,2-diphenyl-1*H*-pyrrol-3-yl)indolin-2-one (**7v**)^[@ref14]^ {#sec3.4.43}

Yield: 52 mg (64%) as pale white solid; mp: 238--239 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.11 (s, 1H), 7.34--7.10 (m, 11H), 6.94 (t, *J* = 8.4 Hz, 3H), 4.62 (s, 1H), 2.38 (s, 3H), 2.33 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 192.3, 177.9, 146.2, 140.1, 139.0, 138.7, 137.6, 133.4, 132.8, 130.3, 130.1, 129.8, 129.2, 128.6, 128.0, 124.3, 121.2, 120.0, 119.8, 111.3, 47.6, 33.4, 12.1 ppm.

### 3-(1-Benzyl-6,6-dimethyl-4-oxo-2-phenyl-4,5,6,7-tetrahydro-1*H*-indol-3-yl)indolin-2-one (**7w**) {#sec3.4.44}

Yield: 34 mg (37%) as pale brown solid; mp: 212--213 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 8.23 (s, 1H), 7.37--7.27 (m, 9H), 6.94--6.89 (m, 5H), 5.12 (s, 2H), 4.49 (s, 1H), 2.51--2.46 (m, 2H), 2.21--2.16 (m, 2H), 1.04 (s, 3H), 0.95 (s, 3H) ppm; ^13^C NMR (CDCl~3~, 125 MHz): δ 192.7, 179.2, 143.4, 142.3, 137.3, 137.2, 130.9, 130.6, 129.9, 128.9, 128.8, 128.7, 127.9, 127.5, 125.6, 124.6, 122.9, 121.6, 116.7, 113.8, 109.2, 51.7, 47.9, 44.7, 43.4, 35.2, 28.1 ppm; IR (KBr): 3145, 3015, 2914, 1709, 1647, 1232 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~31~H~28~N~2~O~2~ \[M + H\]^+^: 461.2228; found: 461.2226.

### 3-(4-Oxo-1,2-diphenyl-4,5,6,7-tetrahydro-1*H*-indol-3-yl)indolin-2-one (**7x**) {#sec3.4.45}

Yield: 34 mg (41%) as white solid; mp: 192--193 °C; ^1^H NMR (CDCl~3~, 500 MHz): δ 7.96 (s, 1H), 7.37--7.33 (m, 3H), 7.27--6.99 (m, 8H), 6.96--6.92 (m, 3H), 4.66 (s, 1H), 2.68--2.64 (m, 2H), 2.39--2.36 (m, 2H), 2.07--2.02 (m, 2H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 193.6, 179.1, 145.1, 142.2, 137.2, 136.9, 130.7, 130.4, 130.1, 129.0, 128.3, 128.0, 127.9, 127.7, 127.6, 123.2, 121.6, 118.0, 114.0, 109.2, 44.6, 37.8, 23.4, 23.1 ppm; IR (KBr): 3255, 3102, 2925, 1712, 1652, 1464 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~28~H~22~N~2~O~2~ \[M + H\]^+^: 419.1760; found: 419.1756.

### Ethyl 4-(2-Oxoindolin-3-yl)-1,5-diphenyl-1*H*-pyrrole-3-carboxylate (**7y**) {#sec3.4.46}

Yield: 49 mg (58%) as white solid; mp: 159--160 °C; ^1^H NMR (CDCl~3~, 400 MHz): δ 8.64 (s, 1H), 7.46 (s, 1H), 7.14--7.09 (m, 7H), 7.01--6.97 (m, 4H), 6.81--6.73 (m, 3H), 4.53 (s, 1H), 3.83--3.78 (q, 2H), 0.86 (t, *J* = 7.0 Hz, 3H) ppm; ^13^C NMR (CDCl~3~, 100 MHz): δ 179.8, 163.8, 141.8, 139.2, 136.5, 131.0, 130.9, 129.2, 129.0, 128.4, 128.1, 127.4, 127.3, 125.5, 123.1, 121.8, 116.7, 115.1, 114.5, 109.3, 59.5, 45.2, 14.1 ppm; IR (KBr): 3315, 2964, 1717, 1471, 1447, 1238 cm^--1^; HRMS (ESI-TOF): *m*/*z* calcd for C~27~H~22~N~2~O~3~ \[M + H\]^+^: 423.1709; found: 423.1704.

Computational Details {#sec3.5}
---------------------

All of the calculations were performed using Gaussian 09 package 2. The geometries of all of the structures were optimized using HF level theory and 3-21g basis set. The single-point energies and NBO charges were calculated using 6-31g(d,p) basis set with B3LYP-level density functional theory.
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